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When investigating the association between brain tumors and mobile phone use, accurate
data on tumor position is essential, due to the highly localized absorption of energy in
the human brain from the radiofrequency fields emitted. We used a point process model
to investigate this association using data that included tumor localization from the multi-
national Interphone Study. Our main analysis included 792 regular mobile phone users
diagnosed with a glioma between 2000–2004. Similar to earlier results, we found a statisti-
cally significant association between the spatial distribution of gliomas and the self-reported
location of the phone. When accounting for preferred side not being exclusively used for
all mobile phone calls, the results were similar. The association was independent of the
cumulative call time or cumulative number of calls. We also observed a significant asso-
ciation between tumor distribution and total cumulative specific energy absorbed at the
tumor’s center of gravity, which had been calculated for a subset of the data. However,
our model uses reported side of mobile phone use, which is potentially influenced by recall
bias. The point process method provides an alternative to previously used epidemiological
designs when including localization in the investigation of brain tumors and mobile phone
use.
Abbreviations: CT, Computerized tomography; IARC, International Agency for Research
on Cancer; MRI, Magnetic resonance image; RF, Radio frequency; RF-EMF, Radio fre-
quency electromagnetic fields; SAR, Specific absorption rate; TCSE, Total cumulative
specific energy; WHO, World Health Organization
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Mobile phone use has increased dramatically within the last three decades in most coun-
tries (1). The extensive use of mobile phones has been followed by concerns about potential
adverse health effects of exposure to radio frequency electromagnetic fields (RF-EMF) emit-
ted by mobile phones (2). RF-EMF were classified as group 2B ‘possibly carcinogenic to
humans’ in May 2011 by the International Agency for Research on Cancer (IARC) (3, 4).
The IARC monograph’s working group considered that the most informative epidemiolog-
ical evidence came from the Swedish case-control studies by Hardell et al. (5) and the
multinational case-control “Interphone” study coordinated by IARC (6). The latter is the
largest investigation of mobile phone use and brain tumors to date. Interphone observed no
increased glioma risk except for the decile with the highest reported cumulative call-time
(>1640 hours) and with uncertain interpretation. The national publications on the Inter-
phone data (7–13) and other studies on the association between RF radiation from mobile
phones and brain tumors (14–23) have shown mixed results. When interpreting these
findings, the timing of the study, the exposure variables of relevance, and methodological
limitations have to be considered (24, 25).
The absorption of energy from RF-EMF in human tissue greatly depends on distance
from the source in addition to factors such as frequency band, network characteristics, and
conditions of use (26). Consequently, increased occurrence of tumors in the part of the
brain closest to the phone would be expected if there were a causal association. Analyses of
all brain tumors together without localization are likely to dilute a risk if present, hence it is
crucial to include localization. Some studies divided the participants into ipsilateral phone
users (participants reporting preferential use of the phone on the same side of the head
as the tumor was localized) and contralateral phone users (the opposite) (6, 9–12, 16, 20–
22). Others investigated the risk of brain tumors separately in the different anatomical
lobes of the brain (6, 12, 14, 16, 19, 21). Some studies estimated the distance between
the brain tumor and the mobile phone and divided cases into those close to the phone
where most energy from RF-EMF is absorbed versus further away (27, 28). Additionally,
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both the specific absorption rate of energy (SAR) inside the tumor (29) and the total
cumulative specific energy (TCSE) for each tumor (30) have been estimated for use as
exposure measures.
Our aim is to use the three-dimensional point process model described in Grell et al.
(31) to analyze the Interphone localization data for glioma and thereby further investi-
gate the association between glioma and mobile phone use. A case-only approach removes
possible differential bias between cases and controls, and the specific tumor localizations
collected in the Interphone study allow detailed analysis of spatial relations. Moreover, we
added a mixing proportion to our model to take into account that self-reported preferred
side of use did not mean exclusive use on that side.
METHODS
The Interphone study included participants from 13 countries (Australia, Canada, Den-
mark, Finland, France, Germany, Israel, Italy, Japan, New Zealand, Norway, Sweden, and
the United Kingdom) and cases were between 30 and 59 years of age when diagnosed
with a first primary glioma, meningioma or acoustic neuroma during study periods of 2–4
years between 2000 and 2004. The study has been described in detail elsewhere (32). We
included only gliomas in our analyses as their putative origin is less spatially confined
compared to those of meningiomas and acoustic neuromas. The Interphone data comprise
2700 glioma cases and tumor localization was performed by neuroradiologists on 1530 of
these cases. The localization could not be determined for all cases due to difficulties in re-
trieving appropriate scans. The computer program GridMaster was created specifically for
recording localizations in the Interphone study and consisted of a three-dimensional grid
map of the human head and brain made up of 1 cm cubes (voxels) (33). Neuroradiologists
recorded the tumor contours and their best estimate of the tumor origin in GridMaster
using radiological images (preferably MRI, otherwise CT) when available (92.2%) or ra-
diology reports otherwise (7.8%); hence, they scaled each brain to match the GridMaster
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brain. Of the 1530 tumors with localization data, 906 had a single voxel marked as the
putative origin, 383 had no putative origin marked, and 241 had several voxels marked as
the putative origin.
Detailed information on past mobile phone use was collected by interview, including
number of calls, duration of calls, use of a hands-free device, preferred side of the head
for mobile phone use, and time since start of use. A regular phone user was defined as
a person who made at least one call per week for a period of 6 months or more. Among
the 1530 glioma cases with recorded localization, 933 were regular phone users. The 597
non-regular phone users and non-users were defined as not exposed and are not included
in our analyses. The lifetime cumulative call time and number of calls excluding use with
hands-free devices were calculated in the Interphone study (32, 34). Absorbed RF energy
is widely used as a quantity of RF exposure in tissue and the TCSE was calculated based
on an algorithm which included, among other things, self-reported call time, laterality of
use, hands-free devices, frequency band, communication system, phone class, and network
characteristics (35) at each location in the GridMaster brain for the 372 Interphone study
subjects with tumor localization from five countries (Australia, Canada, France, Israel,
and New Zealand).
The Interphone interview had a question about which side of the head mobile phones
were generally used with ‘generally’ meaning more than 50% of the time. Of the 933 regular
phone users 265 (28.4%) reported left side, 527 (56.5%) reported right side, 110 (11.8%)
reported both sides and for the remaining 31 (3.3%) the preferred side was unknown.
All diagnoses were histologically confirmed or based on unequivocal diagnostic imaging.
From the morphology codes the tumors were assigned a grade as defined by WHO (36)
but this was only possible for 880 (94.3%) of the regular phone users.
Exposure localization. The ear canals were fully contained within 48 voxels on each side of
the GridMaster head and we defined the location of the exposure source as the geometric
midpoint of the outer area of these voxels. We will refer to this point as the ear. For the
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GridMaster head, the nearest brain tissue is 15 mm and the midline of the brain is 85 mm
in horizontal distance from the ear. We assumed that the energy was emitted at the ear
on the side of the head where the mobile phone was self-reported as generally used.
Tumor localization. We condensed the tumor localization for each of the 792 regular mobile
phone users with self-reported preferred side into a single point. Ideally, this point would
represent the origin of the tumor. However, a glioma can grow diffusely and does not
necessarily form a single, consolidated mass. Actually, 36 of the 1530 tumors comprised
more than one patch of contiguous (i.e., sharing either a vertex, edge or face) voxels. We
reviewed a plot of these tumors and decided to include them with all tumor voxels when
calculating a tumor central point. We calculated the tumor localization point as the ‘center
of gravity’, which has previously been used in analyses of Interphone data (30). It is the
midpoint of the voxel at the shortest distance from the other voxels in the tumor. In the
906 cases with a single voxel marked by the neuroradiologists as the putative origin, the
latter had a mean distance of 4.1 mm from the center of gravity (median 0 mm, 75th centile
10.0 mm, maximum 51 mm). We also calculated the geometric midpoint of the tumor as
an alternative to the center of gravity. The results were similar, see the Web Appendix.
Statistical analyses
The main point process analysis included all 792 subjects with a self-reported preferred
side of use. Each tumor was identified with a single reference location x = (x1, x2, x3) cho-
sen as the gravity center of the whole tumor. The ears were identified with locations xL and
xR. We assume the spatial distribution of tumors in the two brain halves to be symmetrical
and that the susceptibility of the brain tissue is uniform across each hemisphere.
The point process model is described in further detail in Grell et al. (31). Briefly, we as-
sumed that the left-sided users’s and right-sided users’s centers of gravity form independent
Poisson processes with the intensities
λL(x) = λ0(x)g(x− xL, z;α) and λR(x) = ρλ0(x)g(x− xR, z;α) (1)
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where ρ is a nuisance parameter related to the relative number of left-sided and right-sided
users and the baseline intensity λ0(x) reflects the intensity for non-users. The function
g describes the distance relation between tumor and preferred ear. We modeled g as a
piecewise constant decreasing function of the distance in millimeters dL = ||x− xL||
g(dL;α) =


α1 if 0 < dL ≤ 55
α2 if 55 < dL ≤ 75
α3 if 75 < dL ≤ 95
α4 if 95 < dL ≤ 115
1 if dL > 115
(2)
with the added constraint α1 ≥ α2 ≥ α3 ≥ α4 ≥ 1 to ensure a decreasing distance
relation. This was supported by the data subset analyzed in Grell et al. (31). The α-
values represent the change in risk of observing a tumor within the given interval compared
to the baseline intensity. We assume that a possible effect of mobile phone use will not
affect the contralateral hemisphere; consequently, we have fixed g = 1 for distances larger
than 115 mm. The null hypothesis (g = 1 or α = 1) is that occurrence of tumors across
each hemisphere for both the left- and right-sided phone users is similar to the occurrence
of tumors for persons not using mobile phones. If α is significantly higher than 1, the
tumor intensity is significantly higher for the users than the non-users. Note that the
approach does not require the baseline intensity λ0(x) to be estimated (31); hence, the
non-users are not included in the analyses even though they appear in the phrasing of the
null hypothesis. The significance testing was done by simulating 1000 test statistics under
the null hypothesis and calculating the empirical p-value (31). The reported confidence
intervals are the Monte Carlo confidence intervals calculated by bootstrapping. The change
points in equation 2 were chosen using the actual distances to preferred ear in the data
(39.0–147.7 mm) such that the first four intervals were of approximately equal length
starting from the shortest distance. Figure 1 is a naive two-dimensional representation of
the GridMaster head and the intervals. The data are from a three-dimensional model so
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α1 covers part of a ball with a radius of 55 mm, α2 a 20 mm layer outside that ball, etc.
We dichotomized each of the seven variables: sex, tumor grade, age, tumor size, time
since start of mobile phone use, lifetime cumulative phone use, and lifetime cumulative
number of calls using the median for the last four variables. Years of phone use and length
and number of calls are related to the exposure, whereas tumor grade and size are related
to the outcome, but they all entered the model similarly. We stratified our model for each
of these variables z and estimated the eight parameters αj = (αj
1
, α
j
2
, α
j
3
, α
j
4
), j ∈ {0, 1}
corresponding to the model with
g(dL, z;α
0,α1) =


α
j
1
if 0 < dL ≤ 55 and z = j
α
j
2
if 55 < dL ≤ 75 and z = j
α
j
3
if 75 < dL ≤ 95 and z = j
α
j
4
if 95 < dL ≤ 115 and z = j
1 if dL > 115 and z = j.
(3)
We cannot estimate the absolute difference between α0 and α1. Consequently, we cannot
assess whether the tumor intensity is higher for one level of the covariate than the other.
However, the model enables us to investigate whether the covariate alters the distance
relation such that the shape of the function g differs between the two covariate levels.
The preferred side of the head for phone use did not imply exclusive use at the preferred
side; consequently, we redefined our model writing the intensities for left- and right-sided
users as mixtures of the distance relation to the left ear and to the right ear:
λL(x) = λ0(x) (wprefg(x− xL, z;α) + wnonprefg(x− xR, z;α)) ,
λR(x) = ρλ0(x) (wprefg(x− xR, z;α) + wnonprefg(x− xL, z;α)) .
We chose the mixing proportions wpref = 0.75 and wnonpref = 0.25.
We conducted several sensitivity analyses. We changed the exposure variable to the
distance to the point with the highest SAR instead of the preferred ear. The former is 15
mm in horizontal distance from the latter and coincident with the location of the nearest
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brain tissue. In this analysis, we redefined the change points in equation 2 by subtracting
15 mm from each of them. Moreover, we changed the exposure variable to the TCSE at
the tumor point x, E(x), in a model with
g(E(x);β) =


1 if 0 < E(x) ≤ 43
β4 if 43 < E(x) ≤ 186
β3 if 186 < E(x) ≤ 771
β2 if 771 < E(x) ≤ 3514
β1 if E(x) > 3514
(4)
where the change points are the quintiles of TCSE. The interpretation of β is the same as
for α: the change in risk of observing a tumor within the given interval compared to the
(not estimated) risk in non-users. We estimated the model with and without the decreasing
constraint β1 ≥ β2 ≥ β3 ≥ β4 ≥ 1. These analyses included the 324 cases with preferred
laterality of the 372 cases with TCSE.
We estimated the model with smaller steps than in equation 2 and we estimated the
standard model for the subsets used in previous case-only analyses: Denmark; Finland;
Germany; Italy; Norway; Sweden; and UK (N=428 with preferred laterality of 515 in
original paper) (28) and: Australia; Canada; France; Israel; and New Zealand (N=332 of
380) (30).
Because of the uncertainty in the assessment of tumor origin, we conducted the same
analyses as in Grell et al. (31) with the same data subset but using the center of gravity
to see whether the choice of either point was crucial for these results.
The analyses were carried out using R software (37).
RESULTS
Descriptive characteristics of the regular users with a self-reported side of use are pre-
sented in Table 1 and a flow chart is presented in Figure 2.
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Figure 3 shows histograms of the distances from tumor center of gravity to closest ear
for all regular users and the non-users with no marked difference between the two.
Table 2 shows the estimates and 95% confidence intervals for the model with piecewise
constant decreasing distance relation (shown in Figure 4), with exposure variable ‘point
with highest SAR’, and with mixing proportions wpref = 0.75 and wnonpref = 0.25. The
hypothesis of no association with the mobile phone is rejected for all three models with
P < 0.01. The estimates for the first two models are similar. For the model with mixing
proportions, the estimates are higher but the confidence intervals are also wider.
Table 3 shows the results for the standard model with the dichotomized covariates
included one at a time. Moreover, the P -value from the test of no difference in the distance
relation for the two groups is included. The distance relation was unrelated to levels of
sex, age, tumor grade, tumor size, years of mobile phone use and amount of mobile phone
use, whether measured as cumulative call time or cumulative number of calls. The test
of no association with the distance to mobile phone yielded P < 0.01 for each strata (not
shown).
The results with TCSE instead of distance are shown in Table 4 and the relation concurs
with the relation for distance with P < 0.01 when testing g = 1. The association between
TCSE and tumor distribution is close to constant after the first interval with the highest
TCSE.
In Table 5 the results from the sensitivity analysis comparing the center of gravity with
the results from Grell et al. (31) are shown (reported with standard errors as (31)) and the
estimates are similar for both types of tumor points. The results from further sensitivity
analyses are found in the Web Appendix and are similar to those presented in Table 2.
This includes the piecewise constant model with smaller intervals and the results for the
subsamples from Larjavaara et al. (28) and Cardis et al. (30).
DISCUSSION
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This is the first analysis that has modeled the spatial distribution of gliomas in relation
to mobile phone use by using the exact localization data from the full Interphone study.
Our results show that the three-dimensional distribution of gliomas within the brain is
skewed towards the ear self-reported to be preferred for mobile phone use. This applies
also when considering that the preferred side of the head was not used for all mobile
phone calls by assuming all study participants used the preferred side for 75% and the
non-preferred side for 25% of the calls. However, we did not find a difference in distance
relation for different levels of lifelong cumulative phone use and for the persons who had
used their mobile phone less than 200 hours there was still a relation with distance. Neither
did we observe any difference in distance relation for age, sex, tumor grade, tumor size,
time since start of mobile phone use, or cumulative number of phone calls. We found a
significant association between tumor intensity and TCSE, though with lower estimates
than for distance alone.
Our results concur with the observation of a statistically significant excess of gliomas
on the self-reported side of mobile phone use (28). However, Larjavaara et al. (28) did not
observe significantly higher odds for a short distance between glioma and mobile phone for
cases than for speculars (a hypothetical control location). Contrary to our method, they
considered exposure on the same side of the head as the glioma, irrespective of the reported
preferred side of mobile phone use. This avoids potential recall bias but may attenuate any
possible association. Our results contrast with the finding in another study of an increase
of gliomas for persons with the highest level of TCSE applied only for mobile phone use
more than 7 years (30). Restricting our analysis to the subsets used in the two studies did
not markedly change our results.
Studies on the SAR distribution in the human head have shown that the energy ab-
sorption drops considerably after 5 cm with almost all energy being absorbed within the
brain hemisphere closest to the phone (26). Our data had only a small proportion of tumor
points closer than 5 cm to the ear which could be related to our use of the three-dimensional
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gravity point of the glioma. This point has limitations for large, irregular shaped tumors
close to the edge of the brain because these may grow towards the center of the brain
resulting in the gravity point being further from the edge and hence the exposure. For
most of the models, αˆ4 is close to 1 indicating that the size of association with the phone
use is small further than 95 mm away from the phone, in agreement with almost all energy
being absorbed within the ipsilateral hemisphere.
The strengths of this paper include the large number of cases with localization data
and that the localization is used as a continuous measure. Moreover, because our anal-
ysis includes only cases, the findings are not affected by differential bias between cases
and controls (38–41). A limitation is uncertainty about the tumor origin and that the
self-reported side of use may be influenced by systematic and recall bias. Our method
necessitates inclusion of side of mobile phone use. Frequently, cases were aware where
their tumor was located when asked about preferred side of the head for mobile phone use,
which could have caused a systematic over-reporting of ipsilateral use. A recent study with
healthy volunteers reported considerable disagreement between self-reported preferred side
for mobile phone use with a 10–12 months recall, and that measured by a software modi-
fied phone (42). This indicates that our data on self-reported side of phone use might be
influenced by random recall bias. Moreover, the cases reporting a preferred side might not
have used the phone exclusively on that side but occasionally used it on the non-preferred
side. We dealt with the latter by introducing mixing proportions with 75% of use assigned
to the preferred side and 25% assigned to the not preferred side. This could not eliminate
systematic recall bias but it could ameliorate the parameter estimates by not assuming
preferred use to be exclusive use.
Figure 3 shows that the distance to closest ear is similarly distributed for regular users
and for non-users, indicating that mobile phone use does not overall result in tumours being
located closer to the ears. Together with the no relation with phone use, this suggests that
our finding could be a result of recall bias.
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The main exposure measure in our model was distance between tumor and phone but
this is a simplification because the spatial distribution of SAR within the head also depends
on the frequency band and other characteristics (26, 43). Further, the exposure source
was modelled as a single point, though in reality it is mainly the antenna of the phone,
which is frequently embedded in the body of the phone. We modeled the distance relation
as a simple piecewise constant function and it would have been preferable to use also a
model with a continuous distance function, but the data did not support this (31). The
model relies on the assumptions that the tumor baseline intensity in the two brain halves
is symmetrical and is uniform across each hemisphere. This is a simplification because
gliomas occur more frequently in some lobes than others (44) and the susceptibility of the
brain tissue is very likely not completely uniform across each hemisphere because the cells
that gliomas arise from are not uniformly distributed in the brain (45).
Taken together, our results suggest that ever using a mobile phone regularly is asso-
ciated with glioma localization in the sense that more gliomas occurred closer to the ear
on the side of the head where the mobile phone was self-reported to be used the most;
however, this trend was not related to amount of mobile phone use making it less likely
that the association observed is caused by a relation between mobile phone use and cancer
risk. We cannot draw firm conclusions about cause and effect, but our approach shows
several strengths compared with traditional epidemiological approaches though the results
may be affected by recall bias in reported side of phone use. Nevertheless, it provides an
alternative in future mobile phone related research.
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Table 1: Characteristics of the Regular Mobile Phone Users With Preferred Side of Use
From the Interphone Grid Data, N=792
No. %
Sex
Male 508 64.1
female 284 35.9
Age, years
30–39 224 28.3
40–49 257 32.4
50–59 311 39.3
Grade
I 16 2.0
II 315 39.8
III 114 14.4
IV 303 38.3
missing 44 5.6
Tumor size, no. of voxels
1–10 240 30.3
11–20 201 25.4
21–30 138 17.4
31–187 213 26.9
Time since start of use, years
1–3.99 273 34.5
4–6.99 253 31.9
7–9.99 145 19.3
10–22.8 121 15.3
Cum. phone use, hours
0–29.9 207 26.1
30–149.9 191 24.1
150–649.9 196 24.7
650–211, 000 198 25.0
Cum. number of calls
0–999 235 29.7
1, 000–2, 999 145 18.3
3, 000–11, 900 209 26.4
12, 000–506, 000 203 25.6
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Table 2: Estimates and 95% Confidence Intervals for the Interphone Grid Data With Preferred Side of use, N=792. The
αˆs Represent the Elevation in Risk of Observing a Tumor Within a Given Interval Compared to the Assumed Baseline
Risk. The Intervals are Distances From the Ear Preferred for Mobile Phone Use. The Numbers are Number of Tumors
Within a Given Interval.
0–55 mm 55–75 mm 75–95 mm 95–115 mm >115 mm
Model No. αˆ1 95% CI No. αˆ2 95% CI No. αˆ3 95% CI No. αˆ4 95% CI No. - 95% CI
Standard 45 2.37 1.66, 4.56 159 1.75 1.38, 2.34 220 1.42 1.14, 1.81 166 1.10 1.00, 1.49 202 1.00 -
Highest SARa 25 2.62 1.70, 6.33 150 1.92 1.47, 2.60 210 1.38 1.11, 1.80 173 1.10 1.00, 1.45 234 1.00 -
Mixing prop. (0.75/0.25)b 45 9.66 2.84, 39.3 159 3.50 1.96, 8.78 220 2.09 1.36, 3.76 166 1.28 1.00, 2.52 202 1.00 -
Abbreviations: CI, confidence interval.
a The intervals are: 0–40 mm, 40–60 mm, 60–80 mm, 80–100 mm, >100 mm.24
Table 3: Estimates and 95% Confidence Intervals for the Stratified Models for the Interphone Grid Data With Preferred
Side of Use. The αˆs Represent the Elevation in Risk of Observing a Tumor Within a Given Interval Compared to the
Assumed Baseline Risk. The Model Cannot Estimate Absolute Differences in α-values Between Covariate-groups but
the Test can Detect if the Distance Relation Differs Between the two Groups. The Intervals are Distances From the Ear
Preferred for Mobile Phone Use. The Numbers are Number of Tumors Within the Covariate Group.
0–55 mm 55–75 mm 75–95 mm 95–115 mm >115 mm
Covariate No. αˆ1 95% CI αˆ2 95% CI αˆ3 95% CI αˆ4 95% CI - 95% CI P value
a
Female 284 1.85 1.41, 4.04 1.85 1.36, 2.96 1.71 1.17, 2.44 1.00 1.00, 1.41 1.00 - 0.26
Male 508 3.04 1.63, 7.54 1.68 1.26, 2.33 1.31 1.00, 1.78 1.21 1.00, 1.64 1.00 -
Age ≤ 46 years 379 1.86 1.45, 4.37 1.86 1.38, 2.76 1.54 1.10, 2.09 1.00 1.00, 1.34 1.00 - 0.39
Age > 46 years 413 3.06 1.63, 7.29 1.69 1.25, 2.51 1.40 1.03, 1.98 1.36 1.00, 1.91 1.00 -
Grade 1 and 2 331 2.59 1.45, 6.61 1.82 1.25, 2.75 1.15 1.00, 1.76 1.15 1.00, 1.68 1.00 - 0.54
Grade 3 and 4 417 2.16 1.46, 5.01 1.64 1.34, 2.39 1.64 1.23, 2.13 1.08 1.00, 1.62 1.00 -
Tumor size ≤ 18 cm3 401 1.96 1.51, 3.66 1.96 1.48, 2.97 1.70 1.21, 2.28 1.25 1.00, 1.85 1.00 - 0.19
Tumor size > 18 cm3 391 4.09 1.90, 12.0 1.51 1.17, 2.25 1.23 1.00, 1.64 1.00 1.00, 1.40 1.00 -
Years of use < 6 years 461 2.02 1.31, 4.28 1.39 1.13, 1.99 1.39 1.06, 1.81 1.00 1.00, 1.43 1.00 - 0.38
Years of use ≥ 6 years 331 3.27 1.92, 11.3 2.32 1.57, 3.57 1.41 1.00, 2.12 1.24 1.00, 1.85 1.00 -
Cum. phone use < 200 hours 435 1.57 1.29, 3.36 1.57 1.27, 2.22 1.48 1.10, 1.95 1.07 1.00, 1.55 1.00 - 0.37
Cum. phone use ≥ 200 hours 357 4.06 2.03, 11.6 1.94 1.32, 3.02 1.34 1.00, 1.97 1.13 1.00, 1.71 1.00 -
Cum. no. of calls < 4, 000 420 1.55 1.25, 3.42 1.44 1.19, 2.02 1.44 1.10, 1.84 1.00 1.00, 1.37 1.00 - 0.16
Cum. no. of calls ≥ 4, 000 372 3.56 2.05, 9.88 2.26 1.51, 3.38 1.39 1.03, 2.08 1.29 1.00, 1.92 1.00 -
Abbreviations: CI, confidence interval.
a Test of no difference in distance relation between levels of the covariate.
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Table 4: Estimates and 95% Confidence Intervals for the Interphone Grid Data With Preferred Side of Use from Australia,
Canada, France, Israel and New Zealand using Total Cumulative Specific Energy Instead of Distance, N=324. The βˆs
Represent the Elevation in Risk of Observing a Tumor Within a Given Interval Compared to the Assumed Baseline Risk.
The Intervals are TCSE-values Calculated Using Distance to the Ear Preferred for Mobile Phone Use. The Numbers are
Number of Tumors Within a Given Interval.
>3514 J/kg 771–3514 J/kg 186–771 J/kg 43–186 J/kg 0–43 J/kg
Model No. βˆ1 95% CI No. βˆ2 95% CI No. βˆ3 95% CI No. βˆ4 95% CI No. - 95% CI
Piec. constant 82 2.38 1.33, 5.03 57 1.03 0.58, 1.91 58 1.02 0.57, 1.79 66 1.10 0.66, 1.81 61 1.00 -
Decreasinga 82 2.43 1.65, 1.57 57 1.06 1.00, 1.96 58 1.06 1.00, 1.70 66 1.06 1.00, 1.64 61 1.00 -
a Constraint added to the piecewise constant model to ensure decreasing βs.
Table 5: Comparison of Tumor Points for the Interphone Grid Data With Single Voxel Origin Recorded by Neuroradi-
ologists or Calculated Center of Gravity, N=478
0–55 mm 55–75 mm 75–95 mm 95–115 mm >115 mm
Model No. αˆ1 SE No. αˆ2 SE No. αˆ3 SE No. αˆ4 SE No. - SE
Origin pointa 25 1.82 0.32 100 1.82 0.28 127 1.48 0.22 105 1.09 0.18 121 1.00 -
Gravity center 24 1.75 0.58 105 1.68 0.24 126 1.52 0.22 95 1.00 0.13 128 1.00 -
Abbreviations: SE, standard error.
a Result from Grell et al. (31)
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Figure legends
Figure 1
Naive representation of the head with the intervals from the point process model. The
radius of α1 is 55 mm, of α2 75 mm, of α3 95 mm, and of α4 115 mm; the short radius of
the ellipse is 85 mm.
Figure 2
Study Subjects
Figure 3
A) Density Histogram for Distance to Closest Ear for all Regular Users, N=933. B)
Distance to Closest Ear for all Non-users, N=597
Figure 4
Results from the model with piecewise constant decreasing distance relation for the In-
terphone Grid Data With Preferred Side of Use. Step function, αˆ-values representing the
elevation in risk of observing a tumor within a given interval compared to the assumed
baseline risk; Vertical bars, 95% confidence intervals.
27
α1
α2
α3
α4
Sagittal AxisC
or
on
al
 A
xis
Figure 1
2,700 Glioma
Cases
1,530 With
Localisation Data
933 Regular
Phone Users
265 Left Users
527 Right Users
110 Both Users
Figure 2
28
Distance to closest ear in mm
D
en
si
ty
A)
35 55 75 95 115
0.
00
0.
01
0.
02
0.
03
Distance to closest ear in mm
D
en
si
ty
B)
35 55 75 95 115
0.
00
0.
01
0.
02
0.
03
Figure 3
Distance to preferred ear in mm
α^
0 15 30 45 60 75 90 105 120 135 150
0.
5
1.
0
1.
5
2.
0
2.
5
3.
0
3.
5
4.
0
4.
5
5.
0
Figure 4
29
Web Appendix
EXTRA SENSITIVITY ANALYSES
Here follow the results from the extra sensitivity analyses mentioned but not shown in the article: in Table 6 the subsets
in Cardis et al. 2011 (30) and Larjavaara et al. 2011 (28); in Table 7 the standard model with smaller intervals and thus
9 αˆ-parameters instead of 4.
Table 6: Estimates and 95% Confidence Intervals for the standard model for the Interphone Grid Data With Preferred
Side of Use. The αˆs Represent the Elevation in Risk of Observing a Tumor Within a Given Interval Compared to the
Assumed Baseline Risk. The Intervals are Distances From the Ear Preferred for Mobile Phone Use.
0–55 mm 55–75 mm 75–95 mm 95–115 mm >115 mm
Model No. αˆ1 95% CI No. αˆ2 95% CI No. αˆ3 95% CI No. αˆ4 95% CI No. - 95% CI
Cardis et al., N=332 18 1.87 1.34, 4.67 66 1.87 1.21, 2.73 96 1.19 1.00, 1.74 65 1.19 1.00, 1.67 87 1.00 -
Larjavaara et al. N=428 16 2.44 1.58, 5.86 78 1.73 1.40, 2.49 93 1.73 1.29, 2.24 99 1.04 1.00, 1.56 142 1.00 -
Abbreviations: CI, confidence interval.
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Table 7: Estimates and 95% Confidence Intervals for the standard model with smaller intervals for the Interphone Grid
Data With Preferred Side of Use, N=792. The αˆs Represent the Elevation in Risk of Observing a Tumor Within a Given
Interval Compared to the Assumed Baseline Risk. The Intervals are Distances From the Ear Preferred for Mobile Phone
Use.
0–50 mm 50–60 mm 60–70 mm 70–80 mm 80–90 mm
Model No. αˆ1 95% CI No. αˆ2 95% CI No. αˆ3 95% CI No. αˆ4 95% CI No. αˆ5 95% CI
Standard model 13 4.22 1.88, 29.2 69 1.86 1.50, 2.87 83 1.86 1.45, 2.65 81 1.47 1.23, 1.95 117 1.47 1.22, 1.95
90–100 mm 100–110 mm 110–120 mm 120–130 mm >130 mm
Model No. αˆ6 95% CI No. αˆ7 95% CI No. αˆ8 95% CI No. αˆ9 95% CI No. - 95% CI
111 1.47 1.20, 1.93 58 1.02 1.00, 1.64 102 1.00 1.00, 1.33 104 1.00 1.00, 1.31 54 1.00 -
Abbreviations: CI, confidence interval.
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ALTERNATIVE TUMOR POINT: THE GEOMETRIC MIDPOINT
As an alternative to the tumor’s center of gravity, we calculated also the geometric mean of each tumor. We compared
the geometric midpoint and the single voxel marked by neuroradiologists as the origin and in these 906 subjects, the
geometric midpoint was a mean distance of 5.4mm from the origin, with median 4.9, 75th centile 7.3mm and maximum
44mm. The medians of the distance from the ear point to the single voxel marked as the origin and from the ear point
to the geometric midpoint differ less than 2mm. Using this geometric midpoint instead of the center of gravity does not
change any of the results markedly. In Table 8 are shown the results from the standard model. This is similar to the
corresponding result in Table 2 in the article. In Table 9 is shown a comparison of a result from Grell et al. (31) with the
result using the same data subset but the geometric midpoint instead of the recorded origin. The two sets of estimated
αs are similar.
Table 8: Estimates and 95% Confidence Intervals for the standard model for the Interphone Grid Data With Preferred
Side of Use, N=792. The αˆs Represent the Elevation in Risk of Observing a Tumor Within a Given Interval Compared
to the Assumed Baseline Risk. The Intervals are Distances From the Ear Preferred for Mobile Phone Use.
0–55 mm 55–75 mm 75–95 mm 95–115 mm >115 mm
Model No. αˆ1 95% CI No. αˆ2 95% CI No. αˆ3 95% CI No. αˆ4 95% CI No. - 95% CI
Geometric mean 47 2.09 1.60, 3.80 159 1.88 1.48, 2.45 224 1.40 1.15, 1.81 153 1.04 1.00, 1.43 209 1.00 -
Abbreviations: CI, confidence interval.
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Table 9: Comparison of Tumor Points for the Interphone Grid Data With Single Voxel Origin Recorded by Neuroradi-
ologists or Calculated Geometric Midpoint, N=478
0–55 mm 55–75 mm 75–95 mm 95–115 mm >115 mm
Tumor points No. αˆ1 SE No. αˆ2 SE No. αˆ3 SE No. αˆ4 SE No. - SE
Origin pointa 25 1.82 0.32 100 1.82 0.28 127 1.48 0.22 105 1.09 0.18 121 1.00 -
Geometric mean 24 1.70 0.56 105 1.70 0.30 126 1.70 0.30 95 1.00 0.23 128 1.00 -
Abbreviations: SE, standard error.
a Result from Grell et al. (31)
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